Advertisement
GENI vs Z
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GENI is a Hold and Z is a Hold.
GENI in downward trend: 10-day moving average crossed below 50-day moving average on September 14, 2026
The 10-day moving average for GENI crossed bearishly below the 50-day moving average on September 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GENI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
GENI broke above its upper Bollinger Band on October 08, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GENI entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GENI's RSI Indicator exited the oversold zone, 19 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on GENI as a result. In 78 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for GENI just turned positive on October 06, 2026. Looking at past instances where GENI's MACD turned positive, the stock continued to rise in 34 of 41 cases over the following month. The odds of a continued upward trend are 83%.
Following a +4.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where GENI advanced for three days, in 204 of 251 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating steady price growth. GENI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.407) is normal, around the industry mean (1.332). P/E Ratio (59.172) is within average values for comparable stocks, (412.981). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.015) among similar stocks. P/S Ratio (2.232) is also within normal values, averaging (71.888).
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Z's RSI Indicator ascending out of oversold territory
The RSI Oscillator for Z moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 23 of the 31 cases the stock moved higher. This puts the odds of a move higher at 74%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on Z as a result. In 58 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.
The Moving Average Convergence Divergence (MACD) for Z just turned positive on October 08, 2026. Looking at past instances where Z's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
Following a +12.48% 3-day Advance, the price is estimated to grow further. Considering data from situations where Z advanced for three days, in 223 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 52 of 62 cases where Z's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.
The 10-day moving average for Z crossed bearishly below the 50-day moving average on September 11, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where Z declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
Z broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for Z entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.432) is normal, around the industry mean (1.332). P/E Ratio (119.304) is within average values for comparable stocks, (412.981). Projected Growth (PEG Ratio) (0.932) is also within normal values, averaging (17.274). Dividend Yield (0.000) settles around the average of (0.015) among similar stocks. P/S Ratio (2.720) is also within normal values, averaging (71.888).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. Z’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. Z’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
GENI | Z | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 79 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 89 | |
PRICE GROWTH RATING 1..100 | 59 | 82 | |
P/E GROWTH RATING 1..100 | 36 | 99 | |
SEASONALITY SCORE 1..100 | 50 | 23 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GENI's Valuation (62) in the null industry is in the same range as Z (79) in the Information Technology Services industry. This means that GENI’s stock grew similarly to Z’s over the last 12 months.
GENI's Profit vs Risk Rating (100) in the null industry is in the same range as Z (100) in the Information Technology Services industry. This means that GENI’s stock grew similarly to Z’s over the last 12 months.
Z's SMR Rating (89) in the Information Technology Services industry is in the same range as GENI (96) in the null industry. This means that Z’s stock grew similarly to GENI’s over the last 12 months.
GENI's Price Growth Rating (59) in the null industry is in the same range as Z (82) in the Information Technology Services industry. This means that GENI’s stock grew similarly to Z’s over the last 12 months.
GENI's P/E Growth Rating (36) in the null industry is somewhat better than the same rating for Z (99) in the Information Technology Services industry. This means that GENI’s stock grew somewhat faster than Z’s over the last 12 months.
| GENI | Z | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | 1 day ago 74% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 84% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 69% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 70% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 74% |
| TrendMonth ODDS (%) | 1 day ago 87% | 1 day ago 82% |
| Advances ODDS (%) | 7 days ago 81% | 1 day ago 74% |
| Declines ODDS (%) | 2 days ago 82% | 4 days ago 81% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 77% |
| Aroon ODDS (%) | 1 day ago 80% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GENI’s FA Score shows that 0 FA rating(s) are green while Z’s FA Score has 0 green FA rating(s).
- GENI’s FA Score: 0 green, 5 red.
- Z’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GENI’s TA Score shows that 4 TA indicator(s) are bullish while Z’s TA Score has 4 bullish TA indicator(s).
- GENI’s TA Score: 4 bullish, 6 bearish.
- Z’s TA Score: 4 bullish, 5 bearish.
Price Growth
GENI (@Internet Software/Services) experienced а -3.31% price change this week, while Z (@Internet Software/Services) price change was +7.85% for the same time period.
The average weekly price growth across all stocks in the @Internet Software/Services industry was +0.99%. For the same industry, the average monthly price growth was -2.81%, and the average quarterly price growth was -12.97%.
Reported Earning Dates
GENI is expected to report earnings on Nov 11, 2026.
Z is expected to report earnings on Nov 04, 2026.
Industries' Descriptions
@Internet Software/Services (+0.99% weekly)Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.
Advertisement
GENI and
Correlation & Price change
A.I.dvisor indicates that over the last year, GENI has been loosely correlated with PPLI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GENI jumps, then PPLI could also see price increases.
| Ticker / NAME | Correlation To GENI | 1D Price Change % | ||
|---|---|---|---|---|
| GENI | 100% | +7.34% | ||
| PPLI - GENI | 42% Loosely correlated | -0.99% | ||
| DASH - GENI | 40% Loosely correlated | +4.91% | ||
| ZG - GENI | 37% Loosely correlated | +10.80% | ||
| SNAP - GENI | 37% Loosely correlated | +5.57% | ||
| Z - GENI | 36% Loosely correlated | +11.05% | ||
More | ||||
Z and
Correlation & Price change
A.I.dvisor indicates that over the last year, Z has been closely correlated with ZG. These tickers have moved in lockstep 99% of the time. This A.I.-generated data suggests there is a high statistical probability that if Z jumps, then ZG could also see price increases.